RxDoctor Payments Data

Craig McAsey, MD

Adult Reconstructive Orthopaedic Surgery · Alexandria, VANPI 1649436254

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,330 of the $11,440 with a category attached, or 72.8%. Medical Device Business Services, Inc. accounts for 82.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $9,443, 6.4 times the $1,482 reported in 2019.

$11,440in general payments, 2019–2025

Across 30 payments — averaging $381.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$9K
  • Medacta USA, Inc.$1K
  • Johnson & Johnson$253
  • Asahi Intecc USA, Inc.$173
  • Zimmer Biomet$80
  • Smith+Nephew$48
  • plus $66 from 2 others
$20,497in research payments, 2019–2025

Across 6 payments — averaging $3416.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$20K

What the payments were for

  • Consulting fees$8,33073%
  • Travel & lodging$1,84516%
  • Food & beverage$1,26411%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,440 in reported general payments places this provider in the 55th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.

See all adult reconstructive orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$517,285
Medicare patients
740
Services billed
6,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib12$337
Meloxicam35$121
Diclofenac Sodium12$104
Methylprednisolone11$72

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →